Phase II Trial: uPAR-PET/CT for Prognostication in Head- and Neck Cancer

NCT02965001 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
57
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Rigshospitalet, Denmark